Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes
Jay L. P. Fieldhouse,Marie‐Paule E. van Engelen,Dédé Handgraaf,Sterre C. M. de Boer,Jochum J. van ’t Hooft,Sigfried N. T. M. Schouws,Daniël van Grootheest,Cora Kerssens,Flora H. Duits,Argonde C. van Harten,Mardien L. Oudega,Everard G. B. Vijverberg,Yolande A. L. Pijnenburg
DOI: https://doi.org/10.1111/ene.16426
2024-08-25
European Journal of Neurology
Abstract:This longitudinal study (N = 89) revealed distinct trajectories of behavior and social cognition between patients with behavioral variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (PPD). bvFTD showed worsening of symptoms over time, whereas PPD remained stable or improved, with patient‐reported measures detecting no change, highlighting the need to optimize social cognitive assessment methods. Additionally, higher baseline serum neurofilament light levels were associated with faster behavioral decline, suggesting its potential as a prognostic marker in neuropsychiatric populations. Background and purpose Behavioral variant frontotemporal dementia (bvFTD) and primary psychiatric disorders (PPD), such as mood, psychotic, and autism spectrum disorders, share similar clinical characteristics of behavior and social cognition. Better understanding of clinical progression in bvFTD and PPD is essential for adequate disease monitoring and trial design. Methods In this longitudinal study (N = 89), patients with bvFTD and PPD with at least one follow‐up assessment were included from the Social Brain Project of the Alzheimer Center Amsterdam. Behavioral change and social cognitive decline were assessed via informant‐rated questionnaires (Cambridge Behavioral Inventory–Revised, Frontal Behavioral Inventory [FBI], Stereotypy Rating Inventory, Frontotemporal Dementia Rating Scale, Revised Self‐Monitoring Scale [RSMS]‐caregiver) and patient assessment (Ekman 60‐Faces Test, RSMS‐patient, Emotional Contagion Scale). Clinical trajectories (median = 1.4 years, interquartile range = 1.0–2.2) were examined using linear mixed models. In a subsample, associations with baseline serum neurofilament light (sNfL) were examined. Results At baseline, behavioral and social cognitive symptoms were similar between diagnosis groups, except for poorer emotion recognition in bvFTD. Over time, behavioral symptoms worsened in bvFTD, whereas most measures remained stable and the FBI improved in PPD. Regarding social cognition, emotion recognition and caregiver‐reported socioemotional sensitivity worsened in bvFTD and remained stable in PPD. Patient‐reported social cognitive measures did not change over time. Higher sNfL was associated with faster behavioral change. Conclusions Trajectories of behavior and social cognition differentiate bvFTD from PPD, provided that social cognition is not patient‐reported. Therefore, we stress the need to optimize longitudinal social cognitive assessment in bvFTD. sNfL may be a useful prognostic marker of behavioral progression in neuropsychiatric populations.
neurosciences,clinical neurology